Advertisement
Table 1 Characteristic of patients in group with MOF and without MOF
| No MOF (n = 191) | MOF (n = 72) | Statistic | P value | |
|---|---|---|---|---|
| Male, no. (%) | 123 (64.40%) | 42 (58.33%) | x2 = 0.823 | 0.364 |
| Median age, year | 47.00 (39.00–59.00) | 47.50 (39.00–58.75) | Z = − 0.266 | 0.791 |
| History of hypertension, no. (%) | 39 (20.42%) | 19 (26.39%) | x2 = 1.084 | 0.298 |
| History of diabetes, no. (%) | 23 (12.04%) | 8 (11.11%) | x2 = 0.044 | 0.835 |
| Etiology, no. (%) | x2 = 2.968 | 0.397 | ||
| Biliary | 75 (39.27%) | 31 (43.06%) | ||
| Hypertriglyceridemia | 66 (34.56%) | 26 (36.11%) | ||
| Alcoholic | 21 (10.99%) | 3 (4.17%) | ||
| Other | 29 (15.18%) | 12 (16.66%) | ||
| BMI, kg/m2 | 25.55 ± 3.89 | 25.82 ± 3.10 | t = − 0.591 | 0.555 |
| Obese (BMI ≥ 25 kg/m2), no. (%) | 105 (54.97%) | 42 (58.33%) | x2 = 0.239 | 0.625 |
| Routine blood test | ||||
| WBC, × 109/L | 13.47 (8.95–17.29) | 12.97 (10.03–16.73) | Z = − 0.046 | 0.963 |
| NEUT, % | 86.00 (80.50–89.80) | 85.2 (79.55–89.88) | Z = − 0.357 | 0.721 |
| HCT, % | 37.00 (30.50–43.60) | 31.65 (25.05–43.73) | Z = −2.696 | 0.007 |
| PLT, × 109/L | 166.00 (124.00–227.00) | 145.50 (84.50–247.75) | Z = − 1.733 | 0.083 |
| MPV, fL | 12.40 (10.90–13.90) | 12.10 (10.93–13.80) | Z = −0.675 | 0.500 |
| PDW, % | 16.60 (12.80–20.07) | 16.75 (15.00–18.30) | Z = −0.414 | 0.679 |
| Coagulogram | ||||
| PT, seconds | 12.70 (11.80–13.70) | 14.35 (12.33–16.10) | Z = − 4.519 | < 0.001 |
| APTT, seconds | 29.80 (27.10–33.00) | 37.40 (30.93–47.00) | Z = − 5.243 | < 0.001 |
| TT, seconds | 14.90 (13.80–16.90) | 17.00 (15.33–21.35) | Z = − 4.748 | < 0.001 |
| FIB, g/L | 4.60 (3.56–5.90) | 3.73 (2.58–4.64) | Z = − 4.191 | < 0.001 |
| D-dimer, mg/L | 2450.00 (1010.00–4983.00) | 3219.00 (1371.88–5972.50) | Z = − 1.980 | 0.048 |
| TEG | ||||
| R-time, minutes | 5.60 (4.60–6.60) | 6.35 (4.80–8.78) | Z = − 3.014 | 0.003 |
| K-time, minutes | 1.40 (1.10–1.80) | 1.80 (1.30–2.90) | Z = − 4.316 | < 0.001 |
| α, degrees | 70.10 (64.80–73.50) | 64.80 (53.90–72.60) | Z = − 3.901 | < 0.001 |
| MA, mm | 68.90 (63.50–73.50) | 63.55 (54.85–70.68) | Z = − 3.609 | < 0.001 |
| Ly30, % | 0 (0–0.30) | 0 (0–0) | Z = − 1.655 | 0.098 |
| CI | 1.90 (0.40–2.80) | − 0.05(− 3.83–2.38) | Z = − 4.403 | < 0.001 |
| Inflammatory markers | ||||
| CRP, mg/L | 122.30 (31.30–200.00) | 175.65 (85.73–200.00) | Z = − 2.247 | 0.025 |
| IL-6, pg/ml | 33.00 (6.20–95.50,) | 99.95 (44.80–293.90) | Z = −5.612 | < 0.001 |
| PCT, ng/ml | 0.80 (0.23–1.84) | 4.75 (0.60–19.44) | Z = − 5.591 | < 0.001 |
| Renal function | ||||
| BUN, mmol/L | 5.20 (3.61–6.96) | 8.05 (5.27–16.40) | Z = −5.334 | < 0.001 |
| Creatinine, μmol/L | 64.20 (51.00–85.30) | 119.35 (57.00–274.15) | Z = −4.793 | < 0.001 |
| Ca2+, mmol/L | 1.98 (1.79–2.14) | 1.96 (1.72–2.16) | Z = − 0.335 | 0.737 |
| APACHE II score | 9.00 (7.00–11.00) | 14.00 (11.00–15.75) | Z = −7.879 | < 0.001 |
